Qube Research & Technologies (QRT)
ELV icon

Qube Research & Technologies (QRT)’s Elevance Health ELV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25M Sell
11,000
-5,400
-33% -$2M ﹤0.01% 1715
2026
Q1 		$4.8M Sell
16,400
-33,000
-67% -$10.8M 0.01% 1673
2025
Q4 		$17.3M Sell
49,400
-4,100
-8% -$1.39M 0.02% 991
2025
Q3 		$17.3M Buy
53,500
+13,400
+33% +$4.17M 0.02% 971
2025
Q2 		$15.6M Buy
40,100
+27,900
+229% +$11.2M 0.02% 1023
2025
Q1 		$5.31M Buy
12,200
+7,100
+139% +$2.85M 0.01% 1489
2024
Q4 		$1.88M Hold
5,100
– – ﹤0.01% 1899
2024
Q3 		$2.65M Buy
5,100
+4,600
+920% +$2.46M ﹤0.01% 1661
2024
Q2 		$271K Buy
+500
New +$264K ﹤0.01% 2343

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ELV Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Elevance Health (ELV) stake by 468% in Q2 2026, buying an estimated $196M and bringing the position to 640,181 shares worth $248M. The position accounts for 0.23% of the portfolio, ranked #95.

Qube Research & Technologies (QRT) first reported a position in ELV in Q1 2018 and has held it in 26 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Qube Research & Technologies (QRT) held 640,181 shares of Elevance Health worth $248M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 527,464 Elevance Health shares in Q2 2026, an estimated $196M.
  • Elevance Health made up 0.23% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #95 holding.
  • Qube Research & Technologies (QRT) first reported a position in Elevance Health in Q1 2018 and has held it in 26 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.